Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
Active, not recruiting · NCT04301622 · Registry updated 2024-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, avascular necrosis, bone disorder, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, osteonecrosis, rheumatic disorder | Active, not recruiting | Not stated | 2024-03-20 | NCT04301622 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MicroPort Orthopedics Inc. | 19 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Covenant Medical Center | Saginaw | United States | 1 |